Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-1 antagonists for diabetes.
Mandrup-Poulsen T; AIDA study group. Mandrup-Poulsen T, et al. Expert Opin Investig Drugs. 2013 Aug;22(8):965-79. doi: 10.1517/13543784.2013.804060. Epub 2013 May 26. Expert Opin Investig Drugs. 2013. PMID: 23705588 Review.
Interleukin-1-receptor antagonist in type 2 diabetes mellitus.
Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. Larsen CM, et al. N Engl J Med. 2007 Apr 12;356(15):1517-26. doi: 10.1056/NEJMoa065213. N Engl J Med. 2007. PMID: 17429083 Free article. Clinical Trial.
Blockade of interleukin 1 in type 1 diabetes mellitus.
Mandrup-Poulsen T, Pickersgill L, Donath MY. Mandrup-Poulsen T, et al. Nat Rev Endocrinol. 2010 Mar;6(3):158-66. doi: 10.1038/nrendo.2009.271. Nat Rev Endocrinol. 2010. PMID: 20173777 Review.
Cytokines and type 1 diabetes: a numbers game.
Grunnet LG, Mandrup-Poulsen T. Grunnet LG, et al. Diabetes. 2011 Mar;60(3):697-9. doi: 10.2337/db10-1782. Diabetes. 2011. PMID: 21357470 Free PMC article. No abstract available.
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC, Marks JB, Raskin P, Sanda S, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS; Type 1 Diabetes TrialNet Canakinumab Study Group; Pickersgill L, de Koning E, Ziegler AG, Böehm B, Badenhoop K, Schloot N, Bak JF, Pozzilli P, Mauricio D, Donath MY, Castaño L, Wägner A, Lervang HH, Perrild H, Mandrup-Poulsen T; AIDA Study Group. Moran A, et al. Lancet. 2013 Jun 1;381(9881):1905-15. doi: 10.1016/S0140-6736(13)60023-9. Epub 2013 Apr 5. Lancet. 2013. PMID: 23562090 Free PMC article. Clinical Trial.
305 results